Slide 1

Dr H Faruk Buyru stanbul Medical Faculty Dept of Obstet&Gynecol

Slide 2

Artificial Insemination Homologous artificial insemination Heterologous artificial insemination Artificial insemination, husband (AIH) Artificial insemination, donor (AID)

Slide 3

Rationale for the use of IUI Vaginal acidity and servical mucus hostility Concentrated, motile, morphologically normal sperm as close as possible to the oocytes

Slide 4

Main Indications for IUI 1. Ejaculatory failure 2. Cervical factor 3. Mild male subfertility 4. Immunological 5. Unexplained infertility 6. Endometriosis 7. Ovulatory dysfunction 8. HIV positive male partner and HIV-negative female partner 9. Combined infertility factors

Slide 5

Assisted reproductive technology in Europe, 2004: results generated from European registers by ESHRE Andersen et al, Hum Reprod 2008 Apr From 29 countries, 785 clinics, 367,066 cycles including: IVF (114,672), ICSI (167,192), frozen embryo (71,997), egg donation (ED, 10 334), PGD/PGS (2701) and, IVM (170) IUI 115,980 cycles (IUI-H, 98,388; IUI-D, 17,592) No of ET: 1- 19.2%, 2-55.3%, 3-22.1%, 4 or more 3.3% Singleton 77.2 %, twin 21.7%, triplet 1 % Per Aspiration %Per Transfer % Clinical pregnancy- IVF 26.630.1 Clinical pregnancy- ICSI 27.129.8 IUI-H clin pregnancy12.6/per cycle

Slide 6

Steps 1. Ovarian stimulation 2. Monitoring of follicular growth and endometrial development 3. Timing of insemination 4. Semen preparation 5. IUI with prepared sperm

Slide 7

Factors Affecting Success Rate Cause of infertility Age of both partners Duration of infertility Treatment cycle rank Sperm parameters

Slide 8

Clomiphene citrate and intrauterine insemination: analysis of more than 4100 cycles Dovey S et al, Hum Reprod 2008 Retrospective cohort study, Boston IVF 4,199 cycles, 1,738 patients, 2002 - July 2007, CC-IUI Under age 35 years cumulative PRs 24.2 % Ages 35-37 18.5 %Ages 38-40 15.1 % Ages 41-42 7.4 %Above 42 1.8 % Younger patients have a higher PR per cycle than older patients The PR per cycle for patients who initiate only one or only two treatment cycles is notably higher than the corresponding per cycle rates for cycles 3 through 9 The drop in success per patient among 41- and 42-year-olds is sharp, but the exceptionally low success rate above age 42 suggests that CC with IUI has virtually no place in their treatment.

Slide 9

Maternal Age An age-related decline in female fecundity has been documented in women undergoing IUI Successful pregnancy rates decrease after age 35 and reduce dramatically after age 40 Plosker et al, Hum Reprod 1994 Tomlinson et al Hum Reprpd 1996

Slide 10

Duration of Infertility The longer the duration of infertility, the lower the pregnancy rates after IUI The pregnancy rate may be seriously compromised when infertility has lasted 3 or more years Nuojua-Huttunen S et al, Hum Reprod 1999 Plosker et al, Hum Reprod 1994 Steures P et al, Fertil Steril 2004

Slide 11

Slide 12

Semen Analysis Characteristics Total motile sperm count > 5 million Kruger morphology 5% Zayed et al, Hum Reprod 1997 Prewashed semen specimen: More than 4% normal sperm morphology, the chances of pregnancy after IUI were significantly increased van Waart et al, Hum Rerprod Update 2001

Slide 13

Threshold for IUI > 5X10 6

Slide 14

W Ombelet et al.. RBM online 2003

Slide 15

Isolated teratozoospermia

Slide 16

Fertil Steril 2008 393 couples, 714 IUI cycles Prospective observational study

Slide 17

Slide 18

Slide 19

IUI used for treating male factor infertility has little chance of success when the; woman is older than 35 years, the number of motile spermatozoa inseminated is

COST: IVF / IUI Before IVF Cohlen (2005) Gynecol Obstet Invest Review Cervical factor, male factor (TMS> 10 million), unexplained infertility Gonadotropins are more effective than CC Mild ovarian hyperstimulation + IUI is more cost- effective than IVF

Slide 29

Cost-effectivity in tubal factor infertility MildModerateSevere Surgery IVFSurgery IVFSurgery IVF 1986 9400 6162 1112516221 14833 Cost-effectivity in endometriosis MildModerateSevere Surgery IVFSurgery IVFSurgery IVF 2393 9400 8673 11750 34600 19488 Philips, Hum Reprod, 2000 Cost per pregnancy ()

Slide 30

IUI / IVF: Cost-effectiveness Van Voorhis et al (1998) Fertil Steril

Slide 31

Slide 32

Slide 33

Outcome: Per live birth-producing pregnancy IVF:12 600 Unstimulated-IUI + IVF:13.100 Stimulated-IUI + IVF:15.100 Hypothetical cohort of 100 couples: Compared with primary offer IVF, 6 cycles of U-IUI or of S-IUI wolud cost an additional 174.200 and 438.000, representing an opportunity cost of 54 and 136 additional IVF cycles and 14 to 35 live birth-producing pregnancies respectively

Slide 34

For couples with unexplained and mild male factor subfertility, primary offer of a full IVF cycle is less costly and more cost-effective than providing IUI (of any modality) followed by IVF

Slide 35

Intra-uterine insemination for male subfertility Bensdorp AJ, Cohlen BJ, Heineman MJ, Vandekerckhove P Cochrane Syst Rev, 2008-1 IUI versus TI both in natural cycles no evidence of difference (Peto OR 5.3, 95% CI 0.42 to 67) No statistically significant of difference between pregnancy rates (PR) per couple for IUI + OH versus IUI could be found (Peto OR 1.47, 95% CI 0.92 to 2.37) IUI versus TI both in stimulated cycles there was no evidence of statistically significant difference (Peto OR 1.67, 95% CI 0.83 to 3.37) Conclusion: There was insufficient evidence of effectiveness to recommend or advise against IUI with or without OH above TI, or vice versa

Slide 36

Intra-uterine insemination for unexplained subfertility Verhulst SM, Cohlen BJ, Hughes E, te Velde E, Heineman MJ Cochrane Syst Revc 2008-1 IUI vs TI both in stimulated cycles: There was evidence of an increased chance of pregnancy (six RCTs, 517 women: OR 1.68, 95% CI 1.13 to 2.50) A significant increase in live birth rate was found for women where IUI with OH was compared with IUI in natural cycle (four RCTs, 396 women: OR 2.07, 95% CI 1.22 to 3.50). There is evidence that intra-uterine insemination (IUI) improves the odds of becoming pregnant for couples with unexplained subfertility compared to timed intercourse. The addition of fertility drugs to IUI treatment to induce ovulation also improves the chances

Slide 37

Ovarian stimulation protocols (anti-oestrogens, gonadotrophins with and without GnRH agonists/antagonists) for intrauterine insemination (IUI) in women with subfertility Cantineau AEP, Cohlen BJ, Heineman MJ Cochrane Syst Rev 2008-1 Forty three trials involving 3957 women The review compared different drugs for ovarian hyperstimulation showing that injections result in higher pregnancy rates compared with oral medication. However, the evidence for this result is not very strong. This review does not answer the question whether the addition of GnRH agonist or antagonist is use ful.

Slide 38

Advantages of IVF over IUI Higher pregnancy rates Knowledge obtained about fertilization of oocytes Cryopersarvation of spare embryos Severe male-factor infertility Severe endometriosis Tubal damage

Slide 39

Should we still perform IUI as IVF-ICSI is promoting so quickly? All treatment options, side effects, risks and costs should be discussed with the couples IVF/ICSI is more invasive Couples should be informed about the real success rates HFB

Slide 40

Conclusion IUI is relatively an effective method of teratment for certain groups of subfertile couples IUI is less invasive and cheaper than IVF Careful selection of patients is important Patent Fallopian tubes No endometriosis of moderate and severe degree No severe degree of male-factor infertility IVF should be carried out with couples after 4 cycles

Slide 41

Teekkr ederim